CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Revenues	$ 536	$ 540
Cost of revenue	(104)	(116)
Gross profit	432	424
Operating expenses
Selling, general and administrative	7,150	10,181
Research and development cost	1,144	1,576
Operating Expenses, Total	8,294	11,757
Operating loss	(7,862)	(11,333)
Interest and other income/(expense), net	28	66
Gain on sale of Moneygate	81	0
Provision for loan receivable - related party	0	(1,985)
Nonoperating Income (Expense)	109	(1,919)
Net loss from continuing operations before income tax benefit	(7,753)	(13,252)
Income tax benefit	198	336
Net loss from continuing operations before non-controlling interest	(7,555)	(12,916)
Discontinued operations
Net loss from operations of Medicexchange, net of income tax benefit	0	(234)
Gain on sale of Medicexchange, net of income taxes	0	149
Income (Loss) from Discontinued Operations, Net of Tax Including Portion Attributable to Noncontrolling Interest	0	(85)
Net loss before non-controlling interest	(7,555)	(13,001)
Net loss attributable to non-controlling interest	3,006	3,350
Net loss attributable to MGT Capital Investments, Inc.	$ (4,549)	$ (9,651)
Per share data:
Basic and diluted loss per share from continuing operations (in dollars per share)	$ (0.12)	$ (0.29)
Basic and diluted loss per share from discontinued operations (in dollars per share)	$ 0	$ 0
Earnings Per Share, Basic and Diluted (in dollars per share)	$ (0.12)	$ (0.29)
Weighted average number of common shares outstanding (in shares)	39,329,561	32,960,179